Ear, nose, and throat manifestations of COVID-19 and its vaccines

Coronavirus disease 2019 (COVID-19) is a highly infectious disease and was designated a pandemic by the World Health Organization (WHO) on March 11, 2020. There are no classical manifestations of the disease. The most prevalent symptoms include fever, cough, dyspnea, myalgia and headache. The main r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of clinical cases 2022-09, Vol.10 (25), p.8808-8815
1. Verfasser: Al-Ani, Raid M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8815
container_issue 25
container_start_page 8808
container_title World journal of clinical cases
container_volume 10
creator Al-Ani, Raid M
description Coronavirus disease 2019 (COVID-19) is a highly infectious disease and was designated a pandemic by the World Health Organization (WHO) on March 11, 2020. There are no classical manifestations of the disease. The most prevalent symptoms include fever, cough, dyspnea, myalgia and headache. The main route of transmission of the severe acute respiratory syndrome coronavirus-2 is through the upper respiratory tract. Therefore, it is not strange to find different ear, nose and throat (ENT) symptoms in individuals infected with this virus. Olfactory dysfunction is a common feature of COVID-19; either it is the only presenting symptom or it accompanies other manifestations of the disease. Other otolaryngological features such as sudden sensorineural hearing loss (SSNHL), dysphonia, nasal obstruction, sore throat, are less frequent manifestations of COVID-19. These features, in addition, to being presented early in the disease process, certain long-standing symptoms like parosmia, dysphonia, and persistent deafness, are other characteristics of the disease. Geographical variation in otorhinolaryngological prevalence is another problem with this debilitating disease. Local and systemic adverse effects (local site injection pain, fever, myalgia, headache, and others) of the COVID-19 vaccines are more frequent than otolaryngological side effects (anosmia, hyposmia, Bell's palsy, SSNHL, ). We aimed in this review to summarize the early and persistent ENT symptoms of COVID-19 or after the various COVID-19 vaccines.
doi_str_mv 10.12998/wjcc.v10.i25.8808
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9477042</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2718645009</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-fd3a1acafe365d76db110479fcb7d02ecbc94915367dd36aa32f18af5f4e0d4d3</originalsourceid><addsrcrecordid>eNpVkE1PAjEQhhujEYL8AQ9mjx5Y7Mduu72YEEQlIeGiXpuhH1ICW9wuGP-9y4cETzOTeeedmQehW4L7hEpZPHwvtO5vm9LTvF8UuLhAbcqwSAvJ8eVZ3kLdGBcYY0JwTji7Ri3GSS54nrXRYARVLylDtL0ESpPU8ypAnayg9M7GGmofypgElwynH-OnlMi9ytcx2YLWvrTxBl05WEbbPcYOen8evQ1f08n0ZTwcTFLNGK1TZxgQ0OAs47kR3MyaczIhnZ4Jg6nVMy0zSXLGhTGMAzDqSAEud5nFJjOsgx4PvuvNbGWNtmVdwVKtK7-C6kcF8Op_p_Rz9Rm2SmZC4Iw2BvdHgyp8bZrn1MpHbZdLKG3YREUFKXiWYywbKT1IdRVirKw7rSFY7fGrHX7V4FcNfrXD3wzdnR94GvmDzX4Bv3qChQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2718645009</pqid></control><display><type>article</type><title>Ear, nose, and throat manifestations of COVID-19 and its vaccines</title><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Al-Ani, Raid M</creator><creatorcontrib>Al-Ani, Raid M</creatorcontrib><description>Coronavirus disease 2019 (COVID-19) is a highly infectious disease and was designated a pandemic by the World Health Organization (WHO) on March 11, 2020. There are no classical manifestations of the disease. The most prevalent symptoms include fever, cough, dyspnea, myalgia and headache. The main route of transmission of the severe acute respiratory syndrome coronavirus-2 is through the upper respiratory tract. Therefore, it is not strange to find different ear, nose and throat (ENT) symptoms in individuals infected with this virus. Olfactory dysfunction is a common feature of COVID-19; either it is the only presenting symptom or it accompanies other manifestations of the disease. Other otolaryngological features such as sudden sensorineural hearing loss (SSNHL), dysphonia, nasal obstruction, sore throat, are less frequent manifestations of COVID-19. These features, in addition, to being presented early in the disease process, certain long-standing symptoms like parosmia, dysphonia, and persistent deafness, are other characteristics of the disease. Geographical variation in otorhinolaryngological prevalence is another problem with this debilitating disease. Local and systemic adverse effects (local site injection pain, fever, myalgia, headache, and others) of the COVID-19 vaccines are more frequent than otolaryngological side effects (anosmia, hyposmia, Bell's palsy, SSNHL, ). We aimed in this review to summarize the early and persistent ENT symptoms of COVID-19 or after the various COVID-19 vaccines.</description><identifier>ISSN: 2307-8960</identifier><identifier>EISSN: 2307-8960</identifier><identifier>DOI: 10.12998/wjcc.v10.i25.8808</identifier><identifier>PMID: 36157654</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Minireviews</subject><ispartof>World journal of clinical cases, 2022-09, Vol.10 (25), p.8808-8815</ispartof><rights>The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.</rights><rights>The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. 2022</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-fd3a1acafe365d76db110479fcb7d02ecbc94915367dd36aa32f18af5f4e0d4d3</citedby><cites>FETCH-LOGICAL-c332t-fd3a1acafe365d76db110479fcb7d02ecbc94915367dd36aa32f18af5f4e0d4d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477042/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477042/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36157654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al-Ani, Raid M</creatorcontrib><title>Ear, nose, and throat manifestations of COVID-19 and its vaccines</title><title>World journal of clinical cases</title><addtitle>World J Clin Cases</addtitle><description>Coronavirus disease 2019 (COVID-19) is a highly infectious disease and was designated a pandemic by the World Health Organization (WHO) on March 11, 2020. There are no classical manifestations of the disease. The most prevalent symptoms include fever, cough, dyspnea, myalgia and headache. The main route of transmission of the severe acute respiratory syndrome coronavirus-2 is through the upper respiratory tract. Therefore, it is not strange to find different ear, nose and throat (ENT) symptoms in individuals infected with this virus. Olfactory dysfunction is a common feature of COVID-19; either it is the only presenting symptom or it accompanies other manifestations of the disease. Other otolaryngological features such as sudden sensorineural hearing loss (SSNHL), dysphonia, nasal obstruction, sore throat, are less frequent manifestations of COVID-19. These features, in addition, to being presented early in the disease process, certain long-standing symptoms like parosmia, dysphonia, and persistent deafness, are other characteristics of the disease. Geographical variation in otorhinolaryngological prevalence is another problem with this debilitating disease. Local and systemic adverse effects (local site injection pain, fever, myalgia, headache, and others) of the COVID-19 vaccines are more frequent than otolaryngological side effects (anosmia, hyposmia, Bell's palsy, SSNHL, ). We aimed in this review to summarize the early and persistent ENT symptoms of COVID-19 or after the various COVID-19 vaccines.</description><subject>Minireviews</subject><issn>2307-8960</issn><issn>2307-8960</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkE1PAjEQhhujEYL8AQ9mjx5Y7Mduu72YEEQlIeGiXpuhH1ICW9wuGP-9y4cETzOTeeedmQehW4L7hEpZPHwvtO5vm9LTvF8UuLhAbcqwSAvJ8eVZ3kLdGBcYY0JwTji7Ri3GSS54nrXRYARVLylDtL0ESpPU8ypAnayg9M7GGmofypgElwynH-OnlMi9ytcx2YLWvrTxBl05WEbbPcYOen8evQ1f08n0ZTwcTFLNGK1TZxgQ0OAs47kR3MyaczIhnZ4Jg6nVMy0zSXLGhTGMAzDqSAEud5nFJjOsgx4PvuvNbGWNtmVdwVKtK7-C6kcF8Op_p_Rz9Rm2SmZC4Iw2BvdHgyp8bZrn1MpHbZdLKG3YREUFKXiWYywbKT1IdRVirKw7rSFY7fGrHX7V4FcNfrXD3wzdnR94GvmDzX4Bv3qChQ</recordid><startdate>20220906</startdate><enddate>20220906</enddate><creator>Al-Ani, Raid M</creator><general>Baishideng Publishing Group Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220906</creationdate><title>Ear, nose, and throat manifestations of COVID-19 and its vaccines</title><author>Al-Ani, Raid M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-fd3a1acafe365d76db110479fcb7d02ecbc94915367dd36aa32f18af5f4e0d4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Minireviews</topic><toplevel>online_resources</toplevel><creatorcontrib>Al-Ani, Raid M</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of clinical cases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Ani, Raid M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ear, nose, and throat manifestations of COVID-19 and its vaccines</atitle><jtitle>World journal of clinical cases</jtitle><addtitle>World J Clin Cases</addtitle><date>2022-09-06</date><risdate>2022</risdate><volume>10</volume><issue>25</issue><spage>8808</spage><epage>8815</epage><pages>8808-8815</pages><issn>2307-8960</issn><eissn>2307-8960</eissn><abstract>Coronavirus disease 2019 (COVID-19) is a highly infectious disease and was designated a pandemic by the World Health Organization (WHO) on March 11, 2020. There are no classical manifestations of the disease. The most prevalent symptoms include fever, cough, dyspnea, myalgia and headache. The main route of transmission of the severe acute respiratory syndrome coronavirus-2 is through the upper respiratory tract. Therefore, it is not strange to find different ear, nose and throat (ENT) symptoms in individuals infected with this virus. Olfactory dysfunction is a common feature of COVID-19; either it is the only presenting symptom or it accompanies other manifestations of the disease. Other otolaryngological features such as sudden sensorineural hearing loss (SSNHL), dysphonia, nasal obstruction, sore throat, are less frequent manifestations of COVID-19. These features, in addition, to being presented early in the disease process, certain long-standing symptoms like parosmia, dysphonia, and persistent deafness, are other characteristics of the disease. Geographical variation in otorhinolaryngological prevalence is another problem with this debilitating disease. Local and systemic adverse effects (local site injection pain, fever, myalgia, headache, and others) of the COVID-19 vaccines are more frequent than otolaryngological side effects (anosmia, hyposmia, Bell's palsy, SSNHL, ). We aimed in this review to summarize the early and persistent ENT symptoms of COVID-19 or after the various COVID-19 vaccines.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>36157654</pmid><doi>10.12998/wjcc.v10.i25.8808</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2307-8960
ispartof World journal of clinical cases, 2022-09, Vol.10 (25), p.8808-8815
issn 2307-8960
2307-8960
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9477042
source Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Minireviews
title Ear, nose, and throat manifestations of COVID-19 and its vaccines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T21%3A24%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ear,%20nose,%20and%20throat%20manifestations%20of%20COVID-19%20and%20its%20vaccines&rft.jtitle=World%20journal%20of%20clinical%20cases&rft.au=Al-Ani,%20Raid%20M&rft.date=2022-09-06&rft.volume=10&rft.issue=25&rft.spage=8808&rft.epage=8815&rft.pages=8808-8815&rft.issn=2307-8960&rft.eissn=2307-8960&rft_id=info:doi/10.12998/wjcc.v10.i25.8808&rft_dat=%3Cproquest_pubme%3E2718645009%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2718645009&rft_id=info:pmid/36157654&rfr_iscdi=true